Bridging Innovation for Health
From key intermediates to formulation licenses — one accountable party delivers end-to-end
We reason backward from blockbuster drugs to decide which intermediate to make, produce it through a tiered supplier network, prove it with a quality-governance system, and deliver it compliantly via our overseas platform. Formulation licenses, APIs, intermediates and excipients — four categories delivered under one contract by one accountable party.
Recommended for Your Region
Molecules in strongest demand in your region, plus the local registration route
Three delivery tiers, by your stage of trust
Three tiers are not three price bands — they are three depths of collaboration. Start with tier one: judge us on one or two batches.
What we deliver: four categories
Every category is searchable, quotable, and annotated with registration status and document availability.
Why trust us
In cross-border sourcing the biggest cost isn't price — it's the cost of judging whether the other side is reliable. These four are checkable, one by one.
Overseas business platform + industrial investment & holding platform + core operating entity + a dozen specialized subsidiaries and partner companies.
Supplier audits & quality agreements, project quality loop (deviation → CAPA), original spectra and batch records archived together and traceable.
Structured demand → tech review → dispatch coordination → quality feedback → dossier assembly → project board — all six steps logged.
We reason backward from patent cliffs of blockbusters and generic filing pipelines to spot key-intermediate opportunities — explain 'why this one' before price.
How to start
Tell us the product or CAS, spec & quantity, and target country — we return a tech-review conclusion and a commercial proposal within 3 business days. No long-term agreement required first.